JCO Precision Oncology

Published by: American Society of Clinical Oncology  

People

  1. Drilon
    Drilon
  2. Chatila
    Chatila
  3. Ladanyi
    Ladanyi
  4. Weigelt
    Weigelt
  5. Alektiar
    Alektiar
  6. Antonescu
    Antonescu
  7. Carlo
    Carlo
  8. Chi
    Chi
  9. De Stanchina
    De Stanchina
  10. Makker
    Makker

Groups

  1. Department of Medicine (23)
  2. Solid Tumor Oncology Division (23)
  3. GSK Faculty (13)
  4. Department of Pathology and Laboratory Medicine (12)
  5. Human Oncology and Pathogenesis Program (10)
  6. Epidemiology and Biostatistics (8)
  7. Graduate Medical Education (8)
  8. Population Sciences Research Program (8)
  9. Gastrointestinal Oncology Service (7)
  10. Sloan Kettering Institute Postdocs (7)
Search Within
  1. "2022"
Formats
  1. Journal Article (23)
  2. Correspondence (2)
  3. Review (1)
Groups
  1. Department of Medicine (23)
  2. Solid Tumor Oncology Division (23)
  3. GSK Faculty (13)
  4. Department of Pathology and Laboratory Medicine (12)
  5. Human Oncology and Pathogenesis Program (10)
  6. Epidemiology and Biostatistics (8)

More Groups

People
  1. Alexander Drilon (4)
  2. Ahmet Zehir (3)
  3. Britta Weigelt (3)
  4. Marc Ladanyi (3)
  5. Walid Chatila (3)
  6. Anita Bowman (2)

More People

Years
  1. 2022 (26)
Publishers
  1. American Society of Clinical Oncology (26)

Results (26)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Germline genetic and treatment-related risk factors for diabetes mellitus in survivors of childhood cancer: A report from the childhood cancer survivor study and St Jude lifetime cohorts
    Journal Article

    Richard, M. A.; Mostoufi-Moab, S.; Rathore, N.; Baedke, J.; Brown, A. L.; Chanock, S. J.; Friedman, D. N.; Gramatges, M.; Howell, R. M.; Kamdar, K. Y.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Development and validation of a breast cancer polygenic risk score on the basis of genetic ancestry composition
    Journal Article

    Hughes, E.; Wagner, S.; Pruss, D.; Bernhisel, R.; Probst, B.; Abkevich, V.; Simmons, T.; Hullinger, B.; Judkins, T.; Rosenthal, E.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Analysis of circulating tumor DNA to predict risk of recurrence in patients with esophageal and gastric cancers
    Journal Article

    Huffman, B. M.; Aushev, V. N.; Budde, G. L.; Chao, J.; Dayyani, F.; Hanna, D.; Botta, G. P.; Catenacci, D. V. T.; Maron, S. B.; Krinshpun, S.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • State of the biomarker dcience in ovarian cancer: A National Cancer Institute Clinical Trials Planning Meeting Report
    Journal Article

    Ethier, J. L.; Fuh, K. C.; Arend, R.; Konecny, G. E.; Konstantinopoulos, P. A.; Odunsi, K.; Swisher, E. M.; Kohn, E. C.; Zamarin, D.
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Immune checkpoint blockade outcome in small-cell lung cancer and its relationship with retinoblastoma mutation status and function
    Journal Article

    Dowlati, A.; Abbas, A.; Chan, T.; Henick, B.; Wang, X.; Doshi, P.; Fu, P.; Patel, J.; Kuo, F.; Chang, H.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Homologous recombination deficiency in pancreatic cancer: Poly (ADP-ribose) polymerase inhibition, checkpoint inhibition, or a combination of both?
    Correspondence

    Keane, F.; Park, W.; O'Reilly, E. M.
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Prospective clinical genomic profiling of Ewing sarcoma: ERF and FGFR1 mutations as recurrent secondary alterations of potential biologic and therapeutic relevance
    Journal Article

    Ogura, K.; Elkrief, A.; Bowman, A. S.; Koche, R. P.; de Stanchina, E.; Benayed, R.; Mauguen, A.; Mattar, M. S.; Khodos, I.; Meyers, P. A.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Germline SMARCA4 deletion as a driver of uterine cancer: An atypical presentation
    Journal Article

    Navitski, A.; Al-Rawi, D. H.; Makker, V.; Weigelt, B.; Zamarin, D.; Liu, Y.; Arnold, A. G.; Chui, M. H.; Mandelker, D. L.; Walsh, M.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • SRC family kinase inhibition targets YES1 and YAP1 as primary drivers of lung cancer and as mediators of acquired resistance to ALK and epidermal growth factor receptor inhibitors
    Journal Article

    Sato, H.; Kubota, D.; Qiao, H.; Jungbluth, A.; Rekhtman, N.; Schoenfeld, A. J.; Yu, H. A.; Riely, G. J.; Toyooka, S.; Lovly, C. M.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Risk stratification of stage I grade 3 endometrioid endometrial carcinoma in the era of molecular classification
    Journal Article

    Zammarrelli, W. A. 3rd; Kim, S. H.; Da Cruz Paula, A.; Rios-Doria, E. V.; Ehmann, S.; Yeoshoua, E.; Hanlon, E. J.; Zhou, Q.; Iasonos, A.; Alektiar, K. M.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save

    • JCO Precision Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    JCO Precision Oncology 2473-4284 American Society of Clinical Oncology
    JCO Precision Oncology 24734284 American Society of Clinical Oncology
    JCO Precision Oncology 24734284 Unknown
    Jco Precision Oncology Lippincott Williams & Wilkins
    Jco Precision Oncology American Society of Clinical Oncology
    Jco Precision Oncology American Society of Clinical Oncology
    JCO Precision Oncology 2473-4284 American Society of Clinical Oncology
    Unknown (24734284) 24734284 American Society of Clinical Oncology